Patient Reported Outcomes in Large Vessel Vasculitides

被引：0
作者：
Joanna Robson
Sarah Mackie
Catherine Hill
机构：
[1] University of the West of England,Centre for Health and Clinical Research
[2] University Hospitals Bristol and Weston NHF Foundation Trust,Rheumatology Department
[3] University of Leeds,Vascular Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine
[4] Rheumatology Department,Rheumatology Unit
[5] Leeds Teaching Hospital NHS Trust,Division of Medicine
[6] Chapel Allerton Hospital,undefined
[7] The Queen Elizabeth Hospital,undefined
[8] University of Adelaide,undefined
来源：
Current Rheumatology Reports | 2021年 / 23卷
关键词：
Giant cell arteritis; Takayasu arteritis; Patient reported outcome; Clinical trials; Outcomes; Large vessel vasculitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 371 条
[1]  
Jennette JC(2013)2012 revised international Chapel Hill consensus conference nomenclature of vasculitides Arthritis Rheum 65 1-11
[2]  
Falk RJ(2017)Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis BMC Med 15 120-125
[3]  
Bacon PA(2015)Projected worldwide disease burden from giant cell arteritis by 2050 J Rheumatol 42 119-521
[4]  
Basu N(2012)Clinical features of polymyalgia rheumatica and giant cell arteritis Nat Rev Rheumatol 8 509-297
[5]  
Cid MC(2005)Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis Arthritis Rheum 53 293-1495
[6]  
Ferrario F(2017)Trial of Tocilizumab in Giant-cell arteritis N Engl J Med 377 1494-494
[7]  
Flores-Suarez LF(2020)British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary Rheumatology (Oxford) 59 487-30
[8]  
Gross WL(2020)2018 update of the EULAR recommendations for the management of large vessel vasculitis Ann Rheum Dis 79 19-225
[9]  
Guillevin L(2016)Updates in pathophysiology, diagnosis and Management of Takayasu Arteritis Ann Vasc Surg 35 210-415
[10]  
Hagen EC(2010)Takayasu arteritis--advances in diagnosis and management Nat Rev Rheumatol 6 406-825
12345678910